|
AGN's Revenue Growth by Quarter and Year
Allergan Plc's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| AGN Revenue (in millions $) |
FY 2020 |
FY 2019 |
FY 2018 |
FY 2017 |
| IV Quarter |
December |
-
|
4,351.00
|
4,079.70
|
4,326.10
|
| III Quarter |
September |
-
|
4,050.70
|
3,911.40
|
4,034.30
|
| II Quarter |
June |
-
|
4,090.10
|
4,124.20
|
4,007.40
|
| I Quarter |
March |
3,604.40
|
3,597.10
|
3,672.10
|
3,572.90
|
| FY |
|
3,604.40
|
16,088.90
|
15,787.40
|
15,940.70
|
| AGN Revenue first quarter 2020 Y/Y Growth Comment |
Allergan plc reported Revenue growth of 0.2% year on year in the first quarter, to $ 3,604.40 millions, this is lower than Allergan Plc's recent average Revenue increase of 17.86%.
Looking into first quarter results within Biotechnology & Drugs industry 63 other companies have achieved higher Revenue growth. While Allergan Plc' s Revenue increase of 0.2% ranks overall at the positon no. 1855 in the first quarter.
|
| AGN Revenue ( Y/Y Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
- |
6.65 % |
-5.7 % |
24.75 % |
| III Quarter |
September |
- |
3.56 % |
-3.05 % |
11.38 % |
| II Quarter |
June |
- |
-0.83 % |
2.91 % |
8.75 % |
| I Quarter |
March |
0.2 % |
-2.04 % |
2.78 % |
-5.87 % |
| FY |
|
- |
1.91 % |
-0.96 % |
9.4 % |
AGN Revenue (Quarter on Quarter Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
- |
7.41 % |
4.3 % |
7.23 % |
| III Quarter |
September |
- |
-0.96 % |
-5.16 % |
0.67 % |
| II Quarter |
June |
- |
13.71 % |
12.31 % |
12.16 % |
| I Quarter |
March |
-17.16 % |
-11.83 % |
-15.12 % |
3.03 % |
| FY (Year on Year) |
|
- |
1.91 % |
-0.96 % |
9.4 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 208.71 % |
17.86 % |
-35.97 % |
| (Jun 30 2015) |
|
(Jun 30 2016) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 208.71 % |
17.86 % |
-35.97 % |
| (Jun 30 2015) |
|
(Jun 30 2016) |
|
| Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020 |
Allergan Plc's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 78.29 % |
2.47 % |
-40.77 % |
| (Dec 31 2013) |
|
|
| AGN's I. Quarter Q/Q Revenue Comment |
In the I. Quarter 2020 Allergan Plc disclosed fall in Revenue from the previous quarter by -17.16% to $ 3,604.40 millions, from $ 4,351.00 millions achived in the previous reporting period.
If you analyse present shortcoming at the I. Quarter, you should take into consideration, that commonly I. Quarter Revenue occur softer in contrast to the quarter before
Within Biotechnology & Drugs industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Allergan Plc's Revenue growth quarter on quarter, overall rank is 2857. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 78.29 % |
2.47 % |
-40.77 % |
| (Dec 31 2013) |
|
|
| AGN's I. Quarter Q/Q Revenue Comment |
In the I. Quarter 2020 Allergan Plc realized fall in Revenue from the forth quarter by -17.16% to $ 3,604.40 millions, from $ 4,351.00 millions achived in the previous reporting period.
But that's not important concern, as Revenue generally seem to dip in the I. Quarter.
Within Biotechnology & Drugs industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Allergan Plc's Revenue growth quarter on quarter, overall rank is 2857. |
|
Allergan Plc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Mar 31 2020) |
12 Months Ending
(Dec 31 2019) |
12 Months Ending
(Sep 30 2019) |
12 Months Ending
(Jun 30 2019) |
12 Months Ending
(Mar 31 2019) |
| Cumulative Revenue 12 Months Ending |
$ 16,096.20 |
$ 16,088.90 |
$ 15,817.60 |
$ 15,678.30 |
$ 15,712.40 |
| Y / Y Revenue Growth (TTM) |
2.44 % |
1.91 % |
-1.35 % |
-2.96 % |
-2.04 % |
| Year on Year Revenue Growth Overall
Ranking |
# 1845 |
# 1468 |
# 1929 |
# 2665 |
# 2451 |
| Seqeuential Revenue Change (TTM) |
0.05 % |
1.72 % |
0.89 % |
-0.22 % |
-0.48 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1854 |
# 1625 |
# 1670 |
# 2371 |
# 2227 |
| Cumulative Revenue growth
Comment |
Although Allergan Plc's Annual Revenue growth year on year were below company's average 14.61% , Revenue announced in the Mar 31 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.44% year on year, from 1.91% in Dec 31 2019.
In the Healthcare sector 279 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1468 to 1845. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
78.23 % |
3.66 % |
-10.97 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
160.67 % |
14.61 % |
-23.95 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 64 |
| Sector |
# 331 |
| S&P 500 |
# 1854 |
|
| Cumulative Revenue growth
Comment |
Although Allergan Plc's Annual Revenue growth year on year were below company's average 14.61% , Revenue announced in the Mar 31 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.44% year on year, from 1.91% in Dec 31 2019.
In the Healthcare sector 279 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1468 to 1845. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
78.23 % |
3.66 % |
-10.97 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
160.67 % |
14.61 % |
-23.95 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 64 |
| Sector |
# 331 |
| S&P 500 |
# 1854 |
| Companies with similar Revenue fall for the quarter ending Mar 31 2020 within Healthcare Sector | Y/Y Change % | Revenue for the quarter ending Mar 31 2020 | | Allergan plc |  0.20% | $ 0.203 millions | | Lifevantage Corp | 0.12% | $ 0.116 millions | | Vycor Medical Inc | 0.11% | $ 0.110 millions |
|
